Moreover, there was an increase in the expression of the pro-inflammatory cytokine IL-1 gene, which may represent an undesirable effect of the treatment, given the known role of inflammation in promoting CRC carcinogenesis. This evidence concerns the gene IL1B and colorectal carcinoma.